Semaglutide × skye peptides — lab test, October 2025
Janoshik Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 20 mg · Lab measured 20.05 mg
100% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 5 mg on both the label figure and the measured one.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Semaglutide from skye peptides, performed by Janoshik Labs on October 14, 2025. Reported purity: 99.415%. Net content: 20.05 mg against 20 mg labeled (100% of label). Batch SM25-20-002. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Semaglutide from skye peptides
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| SM25-10-003 | 31 Dec 2025 | Janoshik Labs | 99.734% | 118% | Unverified |
| SM25-05-003 | 29 Dec 2025 | Janoshik Labs | 99.197% | 125% | Unverified |
| SM25-05-002 | 21 Oct 2025 | Janoshik Labs | 99.405% | 118% | Unverified |
| SM25-10-002 | 2 Oct 2025 | Janoshik Labs | 99.653% | 115% | Unverified |
| SM25-05-001 | 27 Mar 2025 | Janoshik Labs | 99.209% | 123% | Unverified |
| SM25-10-001 | 27 Mar 2025 | Janoshik Labs | 99.421% | 123% | Unverified |
| SM24-10-007 | 18 Dec 2024 | Janoshik Labs | 99.74% | 121% | Unverified |
| SM24-05-006 | 5 Jun 2024 | Chromate | 99.557% | 125% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion